Sinopharm Group Co Ltd
Sinopharm Group's GHG Emissions Data Preview
In 2024, Sinopharm Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Sinopharm Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Verified Sources Behind Sinopharm Group’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sinopharm Group’s data sources below and access millions more through our Disclosure Search.
Insights into Sinopharm Group's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Sinopharm Group amounted to 226,045.07 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Sinopharm Group decreased by 14.19%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
Sinopharm Group's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Sinopharm Group's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Sinopharm Group were 48,785.71 metric tons of CO₂ equivalent (tCO₂e). a
Has Sinopharm Group reduced its Scope 1 emissions over time?
Since 2022, Sinopharm Group's Scope 1 emissions have decreased by 6.96%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2023), Sinopharm Group's Scope 1 emissions decreased by 10.84%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are Sinopharm Group's Scope 2 emissions?
In 2024, Sinopharm Group reported Scope 2 greenhouse gas (GHG) emissions of 177,259.36 tCO₂e without specifying the calculation method. a
Has Sinopharm Group reduced its Scope 2 emissions over time?
Since 2022, Sinopharm Group's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 11.67%, reflecting a declining long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2023), Sinopharm Group's Scope 2 emissions (Unspecified Calculation Method) fell by 15.07% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a
What methodology does Sinopharm Group use for Scope 2 reporting?
In 2024, Sinopharm Group reported its Scope 2 emissions using an unspecified methodology. a
Sinopharm Group's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Sinopharm Group's Value Chain Emissions
In 2024, Sinopharm Group reported 318,336.83 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of Sinopharm Group includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
Sinopharm Group's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Sinopharm Group's Scope 3 emissions?
In 2024, Sinopharm Group reported total Scope 3 emissions of 318,336.83 metric tons of CO₂ equivalent (tCO₂e). a
Insights into Sinopharm Group’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Sinopharm Group reported Scope 1 greenhouse gas (GHG) emissions of 48,785.71 tCO₂e and total revenues of USD 87,180 millions. This translates into an emissions intensity of 0.56 tCO₂e per millions USD. a
Sinopharm Group's Scope 1 Emissions Intensity Compared to Peers
How does Sinopharm Group's GHG emissions intensity compare to its peers?
In 2024, Sinopharm Group reported a Scope 1 emissions intensity of 0.56 tCO₂e per millions USD. Compared to the peer group median of 9.12 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does Sinopharm Group rank on GHG emissions intensity within its industry?
In 2024, Sinopharm Group ranked 5 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Sinopharm Group among the top performers, with one of the lowest emissions intensities relative to peers. a
Insights into Sinopharm Group's Total Carbon Footprint
In 2024, Sinopharm Group reported a total carbon footprint of 544,381.9 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 106.66% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to Sinopharm Group's total carbon footprint was Scope 3 emissions, accounting for 58.48% of the company's total carbon footprint, followed by Scope 2 emissions at 32.56%. a